Companies › AGEN

AGENUS INC (AGEN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001098972 · EDGAR filings · Updated 2026-07-27

AGENUS INC (AGEN) has reported institutional ownership of 24.0%, with 87 institutional managers holding positions valued at $30.8M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-27 — EFFECT filed
• 2026-07-27 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — SCHEDULE 13G filed
• 2026-07-20 — Shelf registration (S-3) filed
• 2026-07-17 — SCHEDULE 13G filed
• 2026-07-14 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, AGENUS INC has 87 institutional holders and institutional ownership of 24.0%.

Insider activity

Insiders reported 36 transactions (0 buys, 0 sells) across 6 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

CONNECT BIOPHARMA HLDGS LTD (CNTB) · COYA THERAPEUTICS INC (COYA) · COMPUGEN LTD (CGEN) · LENSAR INC (LNSR) · CAPSOVISION INC (CV) · ALPHA TAU MEDICAL LTD (DRTS)